Publications by authors named "Finke J"

The treatment of relapsed/refractory acute myeloid leukemia (AML) is associated with a dismal prognosis. The allogeneic hematopoietic cell transplantation (allo-HCT) is frequently performed as salvage therapy. Reduced intensity conditioning protocols have been developed with the aim of reducing the leukemia burden without increasing their toxicity.

View Article and Find Full Text PDF

Immunological reconstitution after allogeneic hematopoietic cell transplantation (alloHCT) is critical for patient survival. We compared short- and long-term immune reconstitution and clinical endpoints in adult recipients of haploidentical or mismatched T cell replete peripheral blood stem cell transplants (PBSCT) with post-transplant cyclophosphamide as GvHD prophylaxis (PTCY, n = 68) to: (a) patients receiving matched unrelated grafts and anti-T lymphocyte globulin (ATLG) (MUD/ATLG, n = 280); (b) patients with a mismatched donor and ATLG (MM/ATLG, n = 54); and (c) recipients of matched related grafts without ATLG (MRD/NoATLG, n = 97). PTCY was associated with delayed neutrophil engraftment, low NK-cell counts on day 30 and reduced CD8+ cells on days 60-80.

View Article and Find Full Text PDF

We have developed a family of dinuclear complexes using 2,7-disubstituted 1,8-naphthalenediol ligands that bind by molecular recognition to two neighboring phosphate diesters of the DNA backbone with the dinuclear Cu and Ni complexes exhibiting a severe cytotoxicity for human cancer cells. To increase the binding affinity, we intended to synthesize the corresponding dinuclear Fe complex. Surprisingly, we obtained a tetranuclear Fe perylene-based complex instead of the expected dinuclear Fe naphthalene-based complex.

View Article and Find Full Text PDF
Article Synopsis
  • The survival of probiotic microorganisms like Saccharomyces cerevisiae is crucial for their health benefits, necessitating careful handling during production, particularly in drying and tableting processes.* -
  • Previous research identified protective additives for spray-drying and explored the effects of tablet formulation, but there was little focus on the impact of multiple compressions during the tableting process.* -
  • The study found that compressing tablets up to five times does not significantly change tablet strength or microorganism survival, suggesting that earlier findings from single compression studies are applicable, and that the inactivation of probiotics during tableting is linked to porosity reduction rather than compression methods.*
View Article and Find Full Text PDF

High-dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT) is widely used in patients with diffuse large B-cell lymphoma. HDCT/ASCT is associated with increased morbidity in elderly/unfit patients. We retrospectively evaluated the use of reduced intensity conditioning in DLBCL patients.

View Article and Find Full Text PDF

Bronchiolitis obliterans syndrome (BOS), as chronic manifestation of graft-versus-host disease (GVHD), is a debilitating complication leading to lung function deterioration in patients after allogeneic hematopoietic cell transplantation (allo-HCT). In the present study, we evaluated BOS development risk in patients after receiving myeloablative conditioning (MAC) regimens. We performed a retrospective analysis of patients undergoing allo-HCT, who received MAC with busulfan/cyclophosphamid (BuCy, n = 175) busulfan/fludarabin (FluBu4, n = 29) or thiotepa/busulfan/fludarabine (TBF MAC, n = 37).

View Article and Find Full Text PDF

Background: The Community Pharmacy Enhanced Services Network (CPESN) is a clinically integrated network (CIN) of approximately 3500 community-based pharmacies in 48 local networks across the United States. CPESN USA promotes expansion of innovative programs within community-based pharmacies including value-based contracting for patient care services. As opportunities grow, it is important to define strategies and tools needed to implement payer-partner programs.

View Article and Find Full Text PDF
Article Synopsis
  • Primary mediastinal germ-cell tumors (PMGCTs) represent a small percentage of all germ-cell tumors, notably having a poorer prognosis compared to gonadal tumors, with low overall survival rates especially in cases with metastases.
  • A retrospective study assessed the effectiveness of high-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for treating 69 adult male patients with primary mediastinal non-seminoma germ cell tumors (PMNSGCT), primarily using carboplatin/etoposide.
  • Results showed that upfront HDC significantly improved progression-free survival and overall survival rates, with a 2-year overall survival rate of 43.3% for the cohort, while identifying predictors for better
View Article and Find Full Text PDF

The aim of this prospective, international multicenter, pseudorandomized study comparing RICT HCT to standard-of-care chemotherapy in intermediate- or high-risk AML patients 50-70 years using the donor versus no-donor concept. Part 1 included only patients with potential family donors (RD) at the date of HLA-typing of the first potential sibling or CR-date, if later. Part 2 allowed the inclusion of patients without a possible sibling donor using the start of an unrelated donor (URD) search as inclusion date.

View Article and Find Full Text PDF

The Pacific oyster is the most widely cultured shellfish worldwide, but production has been affected by mortality events, including in hatcheries that supply the seed for growers. Several pathogens cause disease in oysters, but in many cases, mortality events cannot be attributed to a single agent and appear to be multifactorial, involving environmental variables and microbial interactions. As an organism's microbiome can provide resilience against pathogens and environmental stressors, we investigated the microbiomes in cohorts of freshly settled oyster spat, some of which experienced notable mortality.

View Article and Find Full Text PDF
Article Synopsis
  • - The study assessed COVID-19 mortality rates among patients receiving Chimeric Antigen Receptor (CAR) T-cell therapy for blood cancers, comparing outcomes across three years (2020, 2021, 2022) during the Omicron period.
  • - There was a significant decline in COVID-19-related mortality: from 43.6% in 2020 to 7.5% in 2022, indicating improvement over time, with year of infection identified as a key predictor of survival.
  • - Although mortality decreased, CAR T-cell recipients still face a higher risk of complications compared to the general population, highlighting the need for ongoing monitoring and preventive measures during their treatment.
View Article and Find Full Text PDF

Improved long-term survival rates after allogeneic hematopoietic cell transplantation (alloHCT) make family planning for young adult cancer survivors an important topic. However, treatment-related infertility risk poses challenges. To assess pregnancy and birth rates in a contemporary cohort, we conducted a national multicenter study using data from the German Transplant Registry, focusing on adult women aged 18 to 40 years who underwent alloHCT between 2003 and 2018.

View Article and Find Full Text PDF

The cold pressor test (CPT) elicits strong cardiovascular reactions activation of the sympathetic nervous system (SNS), yielding subsequent increases in heart rate (HR) and blood pressure (BP). However, little is known on how exposure to the CPT affects cardiac ventricular repolarization. Twenty-eight healthy males underwent both a bilateral feet CPT and a warm water (WW) control condition on two separate days, one week apart.

View Article and Find Full Text PDF
Article Synopsis
  • - In patients with myelodysplastic syndrome (MDS), higher revised International Prognostic Scoring System (IPSS-R) scores are linked to poorer transplant outcomes, leading to the idea that lowering these scores before transplant could be helpful, but there's currently no evidence to back this up.
  • - A study analyzing 1,482 MDS patients found that changes in IPSS-R scores before transplantation did not significantly impact outcomes for untreated patients, while beneficial results were seen in those improved by chemotherapy.
  • - Overall, prior treatments including hypomethylating agents showed no clear advantage in improving transplant outcomes, suggesting that the effectiveness of pre-transplant therapies in altering IPSS-R scores is limited and raising questions about their role in managing
View Article and Find Full Text PDF

Second allogeneic stem cell transplantation (alloSCT2) is among the most effective treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long-term EBMT registry data were used to provide large scale, up-to-date outcome results and to identify factors for improved outcome. Among 1540 recipients of alloSCT2, increasing age, better disease control and performance status before alloSCT2, more use of alternative donors and higher conditioning intensity represented important trends over time.

View Article and Find Full Text PDF

Older adults with acute myeloid leukemia (AML) refractory to initial or reinduction chemotherapy have a dismal prognosis if they do not undergo hematopoietic stem-cell transplantation (HCT). However, data assessing HCT outcomes from different donors are scarce. We evaluated results from a retrospective analysis on patients aged ≥70 years, with AML not in remission who received an allogeneic HCT from HLA-matched sibling donor (MSD), HLA-10/10 matched unrelated donor (MUD), or T-cell replete haploidentical (Haplo) donor, from 2010 to 2021, reported to the ALWP-EBMT database.

View Article and Find Full Text PDF

Purpose: Acute myeloid leukemia (AML) is a disease of older patients. Progress in allogeneic hematopoietic cell transplantation (allo-HCT) allowed the delivery of allo-HCT to older patients. We assessed changes over time in transplant characteristics and outcomes in patients with AML ages 65 years and above.

View Article and Find Full Text PDF
Article Synopsis
  • Management of Richter transformation (RT) poses significant challenges, with patient survival often under one year; this study analyzes outcomes of 66 patients who received allogeneic hematopoietic cell transplantation (allo-HCT) between 2008 and 2018.
  • The majority of patients were treated with reduced intensity conditioning, and 42.4% achieved complete remission (CR) before undergoing allo-HCT, with a median follow-up of 6.6 years.
  • Survival rates were promising, showing 1-year overall survival at 65%, but the study highlights the need for strategies to reduce high rates of non-relapse mortality (NRM) and chronic graft versus host disease (GVHD), which were observed at
View Article and Find Full Text PDF

ATOS is a prospective observational study evaluating the outcome of patients receiving anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation. Primary endpoint was severe GvHD and relapse-free survival (SGRFS). GvHD prophylaxis consisted of ATLG and CSA/ MTX or MMF.

View Article and Find Full Text PDF

Knowing how chromosome recombination works is essential for plant breeding. It enables the design of crosses between different varieties to combine desirable traits and create new ones. This is because the meiotic crossovers between homologous chromatids are not purely random, and various strategies have been developed to describe and predict such exchange events.

View Article and Find Full Text PDF